Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | 0.00% | +8.91% | +139.13% |
07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell Microcap Growth Index | CI |
07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell 3000E Growth Index | CI |
Evolution of the average Target Price on Relmada Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Relmada Therapeutics, Inc.
Goldman Sachs | |
SVB Securities LLC | |
Oppenheimer | |
Guggenheim | |
Truist Securities | |
SVB Leerink | |
Mizuho Securities |
EPS Revisions
- Stock Market
- Equities
- RLMD Stock
- RLMD Stock
- Consensus Relmada Therapeutics, Inc.